News

Gladstone in the News June 2, 2020

Monster or Machine? A Profile of the Coronavirus at 6 Months

The New York Times—Melanie Ott, MD, PhD, director of the Gladstone Institute of Virology, is one of the virologists prominently featured in this detailed account of the COVID-19 pandemic and of scientists’ efforts to understand and fight the coronavirus.

Gladstone Experts COVID-19 Virology Ott Lab

Video June 1, 2020

Exploring Human Microbes through Big Data

In this episode of the Newton Series, Katie Pollard shares how big data allows for deep exploration of the human microbiome.

Gladstone Experts Data Science and Biotechnology Pollard Lab Big Data Microbiome

Gladstone in the News May 31, 2020

Why Do Some People Refuse to Wear Masks? Defiance, Misguided Thinking

San Francisco Chronicle—Wearing a mask is increasingly mandated by businesses and local jurisdictions, but some people have refused to comply. Senior Investigator Warner Greene explains that since the coronavirus is spread by respiratory droplets, a mask is an extremely effective way to reduce transmission.

Gladstone Experts COVID-19 Virology Greene Lab

Gladstone in the News May 29, 2020

How Accurate Are Antibody Tests?

Deep Background with Noah Feldman—Alex Marson, director of the Gladstone-UCSF Institute of Genomic Immunology, shares the results of his lab's evaluation of currently available antibody tests for SARS-CoV-2 infection.

Gladstone Experts COVID-19 Genomic Immunology

Gladstone in the News May 29, 2020

Inspire Awards: Melanie Ott Leads Research into Biology of COVID-19

SF Business Times— Melanie Ott, director of the Gladstone Institute of Virology, was recently named one of the most influential women in Bay Area business by the San Francisco Business Times. She reflects on the similarities between the AIDS crisis and the current COVID-19 pandemic, and describes how her lab has refocused their efforts on the novel virus.

Gladstone Experts COVID-19 Virology Ott Lab

Gladstone in the News May 29, 2020

Inspire Awards: Jennifer Doudna Transforms UC Berkeley Lab to Process COVID-19 Tests

San Francisco Business Times—Early on in the pandemic, Gladstone Senior Investigator Jennifer Doudna, PhD, co-discoverer of CRISPR, recognized the need for safe, reliable, and rapid COVID-19 testing. She quickly mobilized a team of scientists from UC Berkeley, UC San Francisco, and elsewhere to develop a high-throughput detection assay and test vulnerable and at-risk populations in the Bay Area. Doudna was recently named one of the most influential women in Bay Area business by the San Francisco Business Times.

Womens Initiative Gladstone Experts COVID-19 Data Science and Biotechnology Doudna Lab

Article May 28, 2020

Engineering the Next Generation of Cell Therapies

Alexander Marson leads the charge with the new Gladstone-UCSF Institute of Genomic Immunology

Institutional News Genomic Immunology

Video May 28, 2020

Finding Our Way Out: Gladstone’s COVID-19 Research

Get a deeper look at the most promising COVID-19 projects at Gladstone.

Gladstone Experts COVID-19

Gladstone in the News May 26, 2020

Bay Area Must Enable Economic, Equitable Recovery

San Francisco Chronicle—Katie Pollard, director of the Gladstone Institute of Data Science and Biotechnology, joined other Bay Area women scientists in an editorial on how the coronavirus pandemic has caused disproportionate challenges for women’s careers, and threatens to reinforce long-standing inequities in the STEM fields.

Womens Initiative COVID-19 Pollard Lab

Article May 26, 2020

Scientists Uncover Ways HIV Is Sexually Transmitted in Women

HIV remodels its target cells, facilitating spread from the female reproductive tract to the rest of the body, shows a new study at Gladstone Institutes.

News Release Research (Publication) HIV/AIDS Center for HIV Cure Research Virology Disease Models Single Cell

Gladstone in the News May 24, 2020

Love in the Time of Coronavirus: How Families and Friends May Reunite

San Francisco Chronicle—Senior Investigator Warner Greene comments on how people can reduce risks when resuming get-togethers with friends or family.

Gladstone Experts COVID-19 Greene Lab

Video May 21, 2020

Epilepsy: From Mechanism to Treatment

In this edition of the Newton Webinar Series, Jeanne Paz shared her lab’s unique approach to understanding the mechanisms of epilepsy and how it could lead to potential treatments.

Gladstone Experts Epilepsy Neurological Disease Paz Lab

Gladstone in the News May 18, 2020

Combatting COVID-19 with Gladstone’s Warner Greene, MD, PhD

When Science Speaks Podcast—Senior Investigator Warner Greene shares his team’s plan to screen FDA-approved drugs to find those that could be repurposed to fight COVID-19.

Gladstone Experts COVID-19 Virology Greene Lab

Gladstone in the News May 18, 2020

Coronavirus: Trump Predicts Vaccine Delivery by End of 2020. Experts Say That’s Not Likely.

The Mercury News—Scientists are racing to develop and test vaccines to protect people against COVID-19, and clinical trials to determine the efficacy of one leading vaccine candidate are scheduled to begin in July. Melanie Ott, director of the Gladstone Institute of Virology, explained that vaccine development is a lengthy process, and the development of effective therapeutics may come before a vaccine is widely available.

Gladstone Experts COVID-19 Virology Ott Lab

Video May 15, 2020

The Thinking Microscope: Reimagining Science through the Lens of AI and Robotics

Steve Finkbeiner explains how his lab uses machine learning and robotics to find answers to some of the world's most devastating diseases.

Center for Systems and Therapeutics Neurological Disease Finkbeiner Lab Big Data Robotic Microscopy